Kidney Cancer Vaccine Shows Promise in Early Trial
The vaccine generated robust immune response in nine patients with advanced disease
Related Articles
Inflammation and the Brain: How Immune Activity Can Alter Mood and Fuel Anxiety
Studies detailing brain-immune crosstalk could inform treatments for autism, anxiety
Helping the U.S. fight addiction, cancer, other afflictions — Harvard Gazette
Heres’s a snapshot of recent research backed by the partnership between government agencies and higher education.
How A Small Number of Mutations Can Fuel Outbreaks of Western Equine Encephalitis Virus
Study shows how spike protein changes determine the risk of viral outbreaks
Could Migraine Drugs Help Treat Endometriosis?
Research in mice suggests headache medications may reduce symptoms of the gynecologic disorder
OpenAI Says Disciplining Chatbots for Lying Just Makes Them Worse
The company warns against applying strong supervision to chatbots, as they will continue lying and just not admit it.
OpenAI Says Disciplining Chatbots for Lying Just Makes Them Worse
The company warns against applying strong supervision to chatbots, as they will continue lying and just not admit it.
Spatial patterning of fibroblast TGFβ signaling underlies treatment resistance in rheumatoid arthritis
Treatment-refractory rheumatoid arthritis (RA) is a major unmet need, and the mechanisms driving treatment resistance are poorly understood. To identify molecular determinants of RA non-remission,…
New Medical Podcast (Like Winter and the 2024 Red Sox) Offers Bleak Outlook, While Four Books Instill Hope – TimmermanReport.com
As Bostonians tentatively emerge from the bleak cold of another New England winter and begin to search for signs of spring, we instinctively turn to…
Low-Cost Drone Add-Ons From China Let Anyone With a Credit Card Turn Toys Into Weapons of War
Chinese ecommerce giants like Temu and AliExpress sell drone accessories like those used by soldiers in the Russia-Ukraine conflict.
Managing the Risks of Venous Thromboembolisms in Patients with Cancer
Patients with cancer are at a much higher risk of developing venous thromboembolism than the general population.
